PABPC1
Polyadenylate-binding protein 1
Also known as: PAB1, PABP1, PABP1_HUMAN, PABPC2, PABPL1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P11940
- Gene
- PABPC1
- Ensembl
- ENSG00000070756
- Chromosome
- 8
- Canonical length
- 636 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a poly(A) binding protein. The protein shuttles between the nucleus and cytoplasm and binds to the 3' poly(A) tail of eukaryotic messenger RNAs via RNA-recognition motifs. The binding of this protein to poly(A) promotes ribosome recruitment and translation initiation; it is also required for poly(A) shortening which is the first step in mRNA decay. The gene is part of a small gene family including three protein-coding genes and several pseudogenes.[provided by RefSeq, Aug 2010]
Canonical amino-acid sequenceUniProt
636 residues, UniProt reviewed canonical sequence.
>P11940|PABPC1
1 MNPSAPSYPM ASLYVGDLHP DVTEAMLYEK FSPAGPILSI RVCRDMITRR SLGYAYVNFQ
61 QPADAERALD TMNFDVIKGK PVRIMWSQRD PSLRKSGVGN IFIKNLDKSI DNKALYDTFS
121 AFGNILSCKV VCDENGSKGY GFVHFETQEA AERAIEKMNG MLLNDRKVFV GRFKSRKERE
181 AELGARAKEF TNVYIKNFGE DMDDERLKDL FGKFGPALSV KVMTDESGKS KGFGFVSFER
241 HEDAQKAVDE MNGKELNGKQ IYVGRAQKKV ERQTELKRKF EQMKQDRITR YQGVNLYVKN
301 LDDGIDDERL RKEFSPFGTI TSAKVMMEGG RSKGFGFVCF SSPEEATKAV TEMNGRIVAT
361 KPLYVALAQR KEERQAHLTN QYMQRMASVR AVPNPVINPY QPAPPSGYFM AAIPQTQNRA
421 AYYPPSQIAQ LRPSPRWTAQ GARPHPFQNM PGAIRPAAPR PPFSTMRPAS SQVPRVMSTQ
481 RVANTSTQTM GPRPAAAAAA ATPAVRTVPQ YKYAAGVRNP QQHLNAQPQV TMQQPAVHVQ
541 GQEPLTASML ASAPPQEQKQ MLGERLFPLI QAMHPTLAGK ITGMLLEIDN SELLHMLESP
601 ESLRSKVDEA VAVLQAHQAK EAAQKAVNSA TGVPTVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PABPC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 1,213 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 1,213 nTPM
- esophagus: 696 nTPM
- lymph node: 507 nTPM
- tonsil: 499 nTPM
- vagina: 479 nTPM
- appendix: 463 nTPM
Single-cell type
- esophageal apical cells: 8,506 nCPM
- late primary spermatocytes: 2,562 nCPM
- breast secretory cells: 1,926 nCPM
- monocytes: 1,888 nCPM
- monocyte progenitors: 1,719 nCPM
- kupffer cells: 1,655 nCPM
Immune cell
- total PBMC: 570 nTPM
- non-classical monocyte: 471 nTPM
- naive CD4 T-cell: 439 nTPM
- myeloid DC: 422 nTPM
- intermediate monocyte: 406 nTPM
- classical monocyte: 403 nTPM
Brain region
- medulla oblongata: 335 nTPM
- thalamus: 311 nTPM
- choroid plexus: 295 nTPM
- pons: 285 nTPM
- cerebral cortex: 281 nTPM
- white matter: 281 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PABPC1.
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 104 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Disease | ImmuneIEDB
Conditions an epitope on PABPC1 was assayed in.
- rheumatoid arthritis B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.27
- gnomAD pLI
- 1
- gnomAD missense Z
- 4.49
- DepMap mean gene effect
- -0.98
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 18% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- CRD-mediated mRNA stabilization
- mRNA splicing, via spliceosome
- mRNA stabilization
- negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay
- negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
- nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
- positive regulation of cytoplasmic translation
- positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay
- positive regulation of nuclear-transcribed mRNA poly(A) tail shortening
- positive regulation of viral genome replication
- regulatory ncRNA-mediated gene silencing
Molecular functions
- mRNA 3'-UTR binding
- mRNA binding
- poly(A) binding
- poly(U) RNA binding
- RNA binding
- translation activator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA recognition motif domain
- Polyadenylate-binding protein/Hyperplastic disc protein, C-terminal
- RNA recognition motif domain, eukaryotic-type
- Polyadenylate binding protein, human types 1, 2, 3, 4
- Nucleotide-binding alpha-beta plait domain superfamily
- PABP, RNA recognition motif 1
- RNA-binding domain superfamily
- PABC (PABP) domain
- PABP, RNA recognition motif 2
- RNA recognition motif
- MLLE domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PABPC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PABPC1 as an antibody target. Whether an autoantibody or antibody against PABPC1 could matter depends on whether native PABPC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PABPC1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PABPC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...